Pharma had held minority stake in 2019 spinout of mAb, now in Phase III for atrial fibrillation and cancer-associated thrombosis

Company’s Entresto is among first cohort of drugs selected for price-setting under Inflation Reduction Act

Selections underline difficulty in predicting how Inflation Reduction Act will be implemented

After statistically significant cardiovascular outcomes readout this month, Novo reports symptomatic relief in heart failure patients

Can the Swiss pharma crack into the top five in the U.S. market, based on its current pipeline?

Medtronic’s Omar Ishrak appointed chairman

Former analyst will ‘prioritize the portfolio’ as pharma sharpens focus on higher-value launches

Narasimhan’s restructuring reunites oncology with rest of pharma, creates new role of chief strategy & growth officer

Mining decades of clinical practice, three fields are making surrogate endpoints out of common prognostic markers

Overview of status of expedited approval pathways sets stage for BioCentury’s 29th Back to School